BRIEF-GlaxoSmithKline reports submission for UMEC in EU

LONDON, April 26 Fri Apr 26, 2013 5:03am EDT

Related Topics

LONDON, April 26 (Reuters) - GlaxoSmithKline Plc : * Regulatory submission for umeclidinium monotherapy in European union * Regulatory filings for umec monotherapy are imminent in the US and planned in

other countries during 2013

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.